Why is Aarti Pharma falling/rising?

As of 16-Sep, Aarti Pharmalabs Ltd is experiencing a decline in its stock price, currently at Rs 911.55, which reflects a decrease of Rs 26.05 or 2.78%. Today's price summary indicates that the stock has underperformed its sector by 3.06% and has fallen after three consecutive days of gains, reaching an intraday low of Rs 908.35. Despite this decline, the stock has shown strong performance over the past month, with a return of 20.39%, and a year-to-date increase of 32.64%. The company maintains a solid financial position with a low Debt to EBITDA ratio of 0.63 times and a return on capital employed (ROCE) of 16.1, which suggests an attractive valuation compared to its peers.
In the broader market context, the stock's recent performance contrasts with the benchmark Sensex, which has increased by 1.58% over the past week. While Aarti Pharma has generated a significant return of 35.01% over the last year, the overall market has faced negative returns of -2.93% during the same period. This indicates that Aarti Pharma has outperformed the market despite its current decline, reflecting a resilient performance in a challenging environment. The rising investor participation, as evidenced by a 36.81% increase in delivery volume, suggests ongoing interest in the stock, which may support its recovery in the future.